top of page

Killing the Unkillable Cancer Cells

Revolutionary Cancer Therapeutics

Innate Repair Saxony is a preclinical-stage Biotech developing a new therapeutic approach for cancer, with an initial focus on aggressive brain tumors.

We utilize siRNA technology to target the Hes3 Signaling Axis, a molecular mechanism that acts as the Achilles Heel for the cancer stem cells, i.e. those cancer cells that evade current therapies and help the tumor regenerate.

SZ article photo.jpg

Targeting the Hes3 Signaling Axis

An untapped biochemical mechanism

Innate Repair scientists discovered a new molecular mechanism that normal tissues use to promote regeneration after injury. Cancerous tissues exploit it and use it as an alternative way of growing. Targeting the Hes3 Signaling Axis is a completely new anti-cancer approach.

Test Tubes
Our Science

Revolutionary biochemistry


New and Transformative

Pursuing a new molecular mechanism for the first time will open vast opportunities in brain and other types of cancer.


Safety & Scalability

Our molecular target is only expressed in regenerating tissue and cancerous tissue. Mice lacking the target are healthy.

We start with a focus on brain cancer (glioblastoma). However, the work is expandable to many other cancer types.


Protected & Validated

Our IP-protected approach has been validated in multiple systems (biopsies, animal models, in vitro efficacy).


A Vast body of work

22+ years of research with publications in top journals (Nature, PNAS, Diabetes, J Biol Chem etc.) and multiple patents.

Top labs around the world have independently corroborated and extended our published findings.


Selected peer-reviewed publications


Discovery of the Hes3 Axis. Disease modification in ischemic stroke models by its pharmacological over-activation.


Disease modification in Parkinsonian models by the pharmacological over-activation of the Hes3 Axis.


Disease modification in Parkinsonian models by over-activation of the Hes3 Axis and protection of the vasculature.


Killing of cultured glioma cancer stem cells by blocking the Hes3 Axis (with the use of an anti-Hes3 siRNA).


Demonstration that the Hes3 Axis is important for the protection and regeneration of the endocrine pancreas.


The Hes3 Axis promotes pancreatic regeneration after injury with powerful consequences in models of type 1 diabetes.


Pancreatic damage, high fat diet, metformin administration, and aging regulate the Hes3 Axis in the brain.


Glioma cancer stem cells can turn on and off the Hes3 Axis. Different means of killing them are needed in the two states.

About Us

The Company

We are a spin off from the Technische Universitaet Dresden. Through its corporate arm, TUD AG, the University is a shareholder of our parent holding Company, Innate Repair Ltd, which has exclusive rights to additional, oncology related IP. Our team comprises the discoverer of the Hes3 Signaling Axis, investors, medics, and company creators.

Equality, Diversity, Inclusion


Our mission is to help people with serious diseases, together with anyone who can contribute. There is no room for exclusion on this quest. So, bring everything you have and everything you are and you will fit right in.


Innate Repair Saxony GmbH,Goetheallee 35, 01309 Dresden

DeutschlandAmtsgericht: Dresden

bottom of page